Geographic Area
Merck Acquires Curon’s Bispecific Antibody in $1.3B Deal; Legend Biotech Evaluates Options Amid Probes; Amgen’s FDA Filing Reveals Missing Adverse Events
Merck, Curon Biopharmaceutical , Bispecific antibody, Legend Biotech, Amgen, FDA filing, Adverse events, China investigations, CAR-T therapy, Carvykti
Mpox Outbreak in Africa: Siga’s Tpoxx Antiviral Falls Short in Congo Study
mpox, Tpoxx, antiviral, Congo study, Africa outbreak, Siga, tecovirimat
Novo Nordisk’s Wegovy Approved in China: Implications and Future Challenges
Novo Nordisk, Wegovy, semaglutide, obesity treatment, China approval, generic competition, patent expiration, pharmaceutical market
Evotec Announces 400 Job Cuts Amid Market Challenges
Evotec, job cuts, market challenges, restructuring, drug discovery, contract development, manufacturing
Eli Lilly Unveils State-of-the-Art Genetic Medicine Research Center in Boston
Eli Lilly, Boston, genetic medicines, research center, innovation hub, biotech
Metagenomi Halts ALS Research Following Biogen and Ionis Setbacks
Metagenomi, ALS program, Biogen, Ionis, pharmaceutical industry, drug development, layoffs, market challenges
Lilly Opens State-of-the-Art Research and Development Center in Boston
Lilly, Boston, research and development, genetics research, biotech incubator, East Coast hub
Acelyrin Shifts Focus Amid Izokibep Setbacks, Lays Off Staff to Pursue Tepezza’s Market Share
Acelyrin, izokibep, clinical trial setbacks, layoffs, Tepezza, market strategy
Unveiling the Top 11 Biotech Startups to Watch: Join Us for the Awards Gala in Boston
Biotech startups, Endpoints News, awards gala, Boston, biotech industry, innovation, healthcare
BioMarin Restricts Roctavian Sales to U.S., Germany, and Italy Amid Stagnant Sales
BioMarin, Roctavian, hemophilia A gene therapy, U.S., Germany, Italy, sales strategy, profitability, cost reduction